GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

India · Delayed Price · Currency is INR

2,419.10

+12.85 (0.53%)

At close: Apr 16, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	37.49B	34.54B	32.52B	32.78B	29.26B
Pharmaceuticals Growth	8.56%	6.21%	-0.80%	12.05%	-9.27%
Total	37.49B	34.54B	32.52B	32.78B	29.26B
Total Growth	8.56%	6.21%	-0.80%	12.05%	-9.27%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	36.99B	33.92B	31.88B	31.96B	29.11B
India Growth	9.03%	6.42%	-0.26%	9.80%	-9.23%
Foreign	504.66M	614.05M	640.05M	818.97M	146.33M
Foreign Growth	-17.82%	-4.06%	-21.85%	459.67%	-16.19%
Total	37.49B	34.54B	32.52B	32.78B	29.26B
Total Growth	8.56%	6.21%	-0.80%	12.05%	-9.27%

Source: S&P Global Market Intelligence.